380 related articles for article (PubMed ID: 19945296)
1. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.
Venkataswamy MM; Porcelli SA
Semin Immunol; 2010 Apr; 22(2):68-78. PubMed ID: 19945296
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.
Zajonc DM; Kronenberg M
Immunol Rev; 2009 Jul; 230(1):188-200. PubMed ID: 19594637
[TBL] [Abstract][Full Text] [Related]
3. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E; Mattner J
Front Immunol; 2019; 10():1449. PubMed ID: 31293596
[TBL] [Abstract][Full Text] [Related]
4. Innate-like recognition of microbes by invariant natural killer T cells.
Kronenberg M; Kinjo Y
Curr Opin Immunol; 2009 Aug; 21(4):391-6. PubMed ID: 19646850
[TBL] [Abstract][Full Text] [Related]
5. [Recognition of CD1d/glycolipid antigen complex by NKT cells and mechanisms in immune regulation].
Watarai H; Tashiro T; Chiba T; Taniguchi M
Tanpakushitsu Kakusan Koso; 2008 Sep; 53(12 Suppl):1584-9. PubMed ID: 21089371
[No Abstract] [Full Text] [Related]
6. Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells.
Pei B; Vela JL; Zajonc D; Kronenberg M
Ann N Y Acad Sci; 2012 Apr; 1253(1):68-79. PubMed ID: 22352829
[TBL] [Abstract][Full Text] [Related]
7. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
[TBL] [Abstract][Full Text] [Related]
8. [NKT cells: their development, mechanisms and effects of action].
Bojarska-Junak A; Tabarkiewicz J; Roliński J
Postepy Hig Med Dosw (Online); 2013 Feb; 67():65-78. PubMed ID: 23475484
[TBL] [Abstract][Full Text] [Related]
9. Interview: glycolipid antigen presentation by CD1d and the therapeutic potential of NKT cell activation.
Kronenberg M
J Vis Exp; 2007; (10):635. PubMed ID: 18989407
[TBL] [Abstract][Full Text] [Related]
10. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
Maricic I; Girardi E; Zajonc DM; Kumar V
J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
[TBL] [Abstract][Full Text] [Related]
11. Recognition of CD1d-restricted antigens by natural killer T cells.
Rossjohn J; Pellicci DG; Patel O; Gapin L; Godfrey DI
Nat Rev Immunol; 2012 Dec; 12(12):845-57. PubMed ID: 23154222
[TBL] [Abstract][Full Text] [Related]
12. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
[TBL] [Abstract][Full Text] [Related]
13. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
[TBL] [Abstract][Full Text] [Related]
14. Optimizing NKT cell ligands as vaccine adjuvants.
Carreño LJ; Kharkwal SS; Porcelli SA
Immunotherapy; 2014; 6(3):309-20. PubMed ID: 24762075
[TBL] [Abstract][Full Text] [Related]
15. Unique interplay between sugar and lipid in determining the antigenic potency of bacterial antigens for NKT cells.
Girardi E; Yu ED; Li Y; Tarumoto N; Pei B; Wang J; Illarionov P; Kinjo Y; Kronenberg M; Zajonc DM
PLoS Biol; 2011 Nov; 9(11):e1001189. PubMed ID: 22069376
[TBL] [Abstract][Full Text] [Related]
16. Scavenger receptors target glycolipids for natural killer T cell activation.
Freigang S; Landais E; Zadorozhny V; Kain L; Yoshida K; Liu Y; Deng S; Palinski W; Savage PB; Bendelac A; Teyton L
J Clin Invest; 2012 Nov; 122(11):3943-54. PubMed ID: 23064364
[TBL] [Abstract][Full Text] [Related]
17. Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells.
Wang J; Li Y; Kinjo Y; Mac TT; Gibson D; Painter GF; Kronenberg M; Zajonc DM
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1535-40. PubMed ID: 20080535
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
[TBL] [Abstract][Full Text] [Related]
19. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex.
Wun KS; Ross F; Patel O; Besra GS; Porcelli SA; Richardson SK; Keshipeddy S; Howell AR; Godfrey DI; Rossjohn J
J Biol Chem; 2012 Nov; 287(46):39139-48. PubMed ID: 22995911
[TBL] [Abstract][Full Text] [Related]
20. CD1d and natural killer T cells in immunity to Mycobacterium tuberculosis.
Arora P; Foster EL; Porcelli SA
Adv Exp Med Biol; 2013; 783():199-223. PubMed ID: 23468111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
